Health Care & Life Sciences » Biotechnology | Osiris Therapeutics Inc.

Osiris Therapeutics Inc.

Osiris Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
-
Market Cap
$372.88 M
Shares Outstanding
34.53 M
Public Float
16.54 M

Profile

Address
7015 Albert Einstein Drive
Columbia Maryland 21046
United States
Employees -
Website http://www.osiris.com
Updated 09/14/2018
Osiris Therapeutics, Inc. engages in stem cell research and development of pharmaceutical products. Its regenerative medicine targets dermal burns, pressure ulcers, venous leg, diabetic foot ulcers, as well as tissue and bone repair. The company was founded by Peter A.

Financials

View All

Peter A. Friedli
Chairman
Charles A. Reinhart
Director